Latest Methicillin-resistant Staphylococcus aureus Stories
LAUSANNE, Switzerland, October 7, 2014 /PRNewswire/ -- Debiopharm Group(TM)(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that
Topical report “Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014” worked out by Global Markets Direct is now available at MarketPublishers.com.
- Lead Product DALVANCE(TM) a Novel Antibiotic for Unmet Medical Need in Hospital and Outpatient Settings - DUBLIN, Ireland and CHICAGO, Oct.
Company Completes Enrollment in Phase 2 Clinical Trial AUSTIN, Texas, Oct.
ROUND ROCK, Texas, Oct.
CHICAGO, Oct. 1, 2014 /PRNewswire-USNewswire/ -- 'The MRSA Epidemic - A Call to Action' is this year's global theme.
PDI Sani-Hands® Instant Hand Sanitizing Wipes Provide Clinical Efficacy as well as Convenience for Healthcare Workers and Patients ORANGEBURG, N.Y., Sept.
Transmission of bacterial infections, including MRSA and MSSA could be curbed by coating hospital surfaces with microscopic bumps that mimic the scaly surface of shark skin, according to research published in the open access journal Antimicrobial Resistance and Infection Control.
- To swell, as grain or wood with water.